BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3777 related articles for article (PubMed ID: 6607104)

  • 1. Immune responses of DBA/2 mice bearing melanoma tumors: cell-mediated immune responses after challenge with vaccinia virus.
    Byrne JA; Soloski M; Holowczak JA
    Cancer Immunol Immunother; 1983; 16(2):81-7. PubMed ID: 6607104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of DBA/2 or C3H/HeJ mice by intraperitoneal injection of vaccinia virus elicits activated macrophages, cytolytic and cytostatic for S91-melanoma tumor cells.
    Natuk RJ; Byrne JA; Holowczak JA
    Cancer Immunol Immunother; 1986; 22(3):197-203. PubMed ID: 3731205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
    Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J
    J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity.
    Hatfield SD; Daniels KA; O'Donnell CL; Waggoner SN; Welsh RM
    Virology; 2018 Jun; 519():131-144. PubMed ID: 29715623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
    Koszinowski U; Thomssen R
    Eur J Immunol; 1975 Apr; 5(4):245-51. PubMed ID: 1086229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1159-64. PubMed ID: 300399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells vs cytotoxic T cells in the peripheral blood of virus-infected mice.
    Stitz L; Althage A; Hengartner H; Zinkernagel R
    J Immunol; 1985 Jan; 134(1):598-602. PubMed ID: 2981094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of a cell-mediated cytotoxic response to FeLV-induced T cell lymphomas in the cat.
    Tompkins MB; Tompkins WA
    J Immunol; 1985 Oct; 135(4):2817-23. PubMed ID: 2993416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.
    Karupiah G; Coupar BE; Andrew ME; Boyle DB; Phillips SM; Müllbacher A; Blanden RV; Ramshaw IA
    J Immunol; 1990 Jan; 144(1):290-8. PubMed ID: 2295796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonspecific cytotoxicity of vaccinia-induced peritoneal exudates in hamsters is mediated by Thy-1.2 homologue-positive cells distinct from NK cells and macrophages.
    Yang H; Tompkins WA
    J Immunol; 1983 Nov; 131(5):2545-50. PubMed ID: 6195269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD69 Deficiency Enhances the Host Response to Vaccinia Virus Infection through Altered NK Cell Homeostasis.
    Notario L; Alari-Pahissa E; de Molina A; Lauzurica P
    J Virol; 2016 Jul; 90(14):6464-6474. PubMed ID: 27147744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.
    Actor JK; Shirai M; Kullberg MC; Buller RM; Sher A; Berzofsky JA
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):948-52. PubMed ID: 8094248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.
    Schütz A; Oertli D; Marti WR; Noppen C; Padovan E; Spagnoli GC; Heberer M; Zajac P
    Cancer Gene Ther; 2001 Sep; 8(9):655-61. PubMed ID: 11593334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-immune and alloreactive response characteristics of thymocytes and spleen cells from young mice.
    Schwartz DH; Doherty PC
    J Immunol; 1981 Oct; 127(4):1411-4. PubMed ID: 6974190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of memory cell-mediated immune responses after secondary infection of mice with pichinde virus.
    Walker CM; Rawls WE; Rosenthal KL
    J Immunol; 1984 Jan; 132(1):469-74. PubMed ID: 6317748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
    Bukowski JF; Woda BA; Habu S; Okumura K; Welsh RM
    J Immunol; 1983 Sep; 131(3):1531-8. PubMed ID: 6309965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells.
    Shimizu Y; Fujiwara H; Ueda S; Wakamiya N; Kato S; Hamaoka T
    Eur J Immunol; 1984 Sep; 14(9):839-43. PubMed ID: 6236991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Shimizu Y; Takai Y; Wakamiya N; Ueda S; Kato S; Hamaoka T
    Eur J Immunol; 1984 Feb; 14(2):171-5. PubMed ID: 6199215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 189.